A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination with Systemic Corticosteroids in ambulatory subjects with Duchenne Muscular Dystrophy (DMD)

Is this Study for You?

Let's Get Started!

Details
Age

Child

Type of Study

Treatment

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Joanne Janas,  MD

Joanne Janas, MD

Study ID

Protocol Number: 20-2929

More information available at ClinicalTrials.gov: NCT04632940

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers